These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 19923096)

  • 1. [Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease].
    Hagymási K; Reismann P; Rácz K; Tulassay Z
    Orv Hetil; 2009 Nov; 150(48):2173-81. PubMed ID: 19923096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine and liver interaction: the role of endocrine pathways in NASH.
    Loria P; Carulli L; Bertolotti M; Lonardo A
    Nat Rev Gastroenterol Hepatol; 2009 Apr; 6(4):236-47. PubMed ID: 19347015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.
    Baranova A; Tran TP; Birerdinc A; Younossi ZM
    Aliment Pharmacol Ther; 2011 Apr; 33(7):801-14. PubMed ID: 21251033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women.
    Rodrigues MH; Bruno AS; Nahas-Neto J; Santos ME; Nahas EA
    Gynecol Endocrinol; 2014 May; 30(5):325-9. PubMed ID: 24460502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of hepatic steatosis: the link between hypercortisolism and non-alcoholic fatty liver disease.
    Tarantino G; Finelli C
    World J Gastroenterol; 2013 Oct; 19(40):6735-43. PubMed ID: 24187449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic steatohepatitis and metabolic syndrome.
    Machado M; Cortez-Pinto H
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models.
    den Boer M; Voshol PJ; Kuipers F; Havekes LM; Romijn JA
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):644-9. PubMed ID: 14715643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adipocitokines and nonalcoholic steatohepatitis].
    Lăcătuşu C; Mihai B; Cijevschi-Prelipcean C; Mihai C; Graur M
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):882-9. PubMed ID: 20209757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology, pathogenesis and histopathology of fatty liver disease.
    Levene AP; Goldin RD
    Histopathology; 2012 Aug; 61(2):141-52. PubMed ID: 22372457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine testing in obesity.
    Wilding JPH
    Eur J Endocrinol; 2020 Apr; 182(4):C13-C15. PubMed ID: 32061161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
    Ságodi L; Lombay B; Vámosi I; Barkai L
    Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: do androgens play a role?
    Kauffman RP; Baker TE; Baker V; Kauffman MM; Castracane VD
    Gynecol Endocrinol; 2010 Jan; 26(1):39-46. PubMed ID: 20001571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of steatosis in nonalcoholic fatty liver disease.
    Pettinelli P; Obregón AM; Videla LA
    Nutr Hosp; 2011; 26(3):441-50. PubMed ID: 21892559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome and nonalcoholic fatty liver disease.
    Collantes RS; Ong JP; Younossi ZM
    Panminerva Med; 2006 Mar; 48(1):41-8. PubMed ID: 16633331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver abnormalities and endocrine diseases.
    Burra P
    Best Pract Res Clin Gastroenterol; 2013 Aug; 27(4):553-63. PubMed ID: 24090942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of obesity and metabolic syndrome on chronic hepatitis C.
    Goossens N; Negro F
    Clin Liver Dis; 2014 Feb; 18(1):147-56. PubMed ID: 24274870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
    Tarantino G; Saldalamacchia G; Conca P; Arena A
    J Gastroenterol Hepatol; 2007 Mar; 22(3):293-303. PubMed ID: 17295757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
    Yki-Järvinen H
    Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic-pituitary-adrenal axis?
    Doi SA; Towers PA; Scott CJ; Al-Shoumer KA
    Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):4-16. PubMed ID: 15596265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.